[
  {
    "ts": null,
    "headline": "Earnings are growing at Zoetis (NYSE:ZTS) but shareholders still don't like its prospects",
    "summary": "Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...",
    "url": "https://finnhub.io/api/news?id=073c98649c12ec4681d1ecc31dcc2373eb944d3c0aa6af837570303666affd8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764943218,
      "headline": "Earnings are growing at Zoetis (NYSE:ZTS) but shareholders still don't like its prospects",
      "id": 137697410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...",
      "url": "https://finnhub.io/api/news?id=073c98649c12ec4681d1ecc31dcc2373eb944d3c0aa6af837570303666affd8d"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats",
    "summary": "PARSIPPANY, N.J., December 05, 2025--Zoetis Inc. today announced that Health Canada has approved Portela™ (relfovetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in cats. Designed to provide three months of OA pain relief with a single injection, Portela targets anti-nerve growth factor (NGF), which is a key mediator of OA pain and inflammation.",
    "url": "https://finnhub.io/api/news?id=7c47c141fd6c949a3c4c06e521e8fe6e468ce3ffe33458a6c3238c8a9b8403ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764941400,
      "headline": "Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats",
      "id": 137697412,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "PARSIPPANY, N.J., December 05, 2025--Zoetis Inc. today announced that Health Canada has approved Portela™ (relfovetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in cats. Designed to provide three months of OA pain relief with a single injection, Portela targets anti-nerve growth factor (NGF), which is a key mediator of OA pain and inflammation.",
      "url": "https://finnhub.io/api/news?id=7c47c141fd6c949a3c4c06e521e8fe6e468ce3ffe33458a6c3238c8a9b8403ef"
    }
  }
]